[SYRE] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -15.23%
YoY- -111.44%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 1,362 0 0 0 1,510 982 859 7.98%
PBT -24,436 -18,218 -18,728 -17,167 -8,119 -6,247 -4,547 32.33%
Tax 0 0 0 0 0 0 0 -
NP -24,436 -18,218 -18,728 -17,167 -8,119 -6,247 -4,547 32.33%
Tax Rate - - - - - - - -
Total Cost 25,798 18,218 18,728 17,167 9,629 7,229 5,406 29.73%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -1,794.13 0.00 0.00 0.00 -537.68 -636.15 -529.34 22.54%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -9.26 -6.94 -14.15 -14.79 -12.17 -11.68 -9.95 -1.19%
EPS Diluted -9.26 -6.94 -14.15 -14.79 -12.17 -11.68 -9.95 -1.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.